what is glp 1 receptor Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Regulation of GLP-1 and Glucagon

Endoplasmic reticulum (ER) stress is another critical etiology in the OA pathological process 9,10,11

Christensen M, Sparre-Ulrich AH, Hartmann B, Grevstad U, Rosenkilde MM, Holst JJ, et al

The site, which provides a robust but not-exhaustive snapshot of clinical trial activity, cites more than 290 unique studies involving the class, while roughly 150 total studies focus on the traditional mainstay, metformin, with roughly 25 studies of those investigating the combined use of GLP-1 receptor agonists with the drug

2022 JAMA Internal Medicine meta-analysis: pooling 76 randomised controlled trials, GLP-1 receptor agonist use was associated with a relative risk of 1.37 for biliary disease compared with placebo or other treatments

J Neurogastroenterol Motil 2016

Relevant literature includes pharmacodynamic studies, gastric motility investigations, endoscopic findings, perioperative observational studies, anesthesia-related case reports, and emerging population-level outcome data